论文部分内容阅读
先前研究显示,对淋巴结阳性的可手术乳腺癌患者而言,联合蒽环类和紫杉烷类药物进行化疗可有效改善患者的生存率(disease-free survival,DFS)和总生存率(overall survival,OS)。
Previous studies have shown that chemotherapy combined with anthracyclines and taxanes in patients with node-positive operable breast cancer can effectively improve the patient’s disease-free survival (DFS) and overall survival (overall survival , OS).